These findings are clinically relevant as CD4+CD161+T-cells in TB patients exhibit a loss or reduced the ability to inhibit the growth of intracellular mycobacteria as well as to produce perforin and IFN-γ. The gene discussed is PRF1; the disease is tuberculosis.